SG Americas Securities LLC Makes New Investment in Henry Schein, Inc. (NASDAQ:HSIC)

SG Americas Securities LLC bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 314,666 shares of the company's stock, valued at approximately $21,551,000. SG Americas Securities LLC owned about 0.25% of Henry Schein at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. GAMMA Investing LLC boosted its stake in Henry Schein by 37.8% in the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after purchasing an additional 1,081 shares during the period. Farther Finance Advisors LLC grew its holdings in shares of Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock valued at $186,000 after buying an additional 1,898 shares in the last quarter. UMB Bank n.a. raised its position in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the period. City State Bank lifted its stake in Henry Schein by 115.6% in the 1st quarter. City State Bank now owns 1,725 shares of the company's stock worth $118,000 after acquiring an additional 925 shares in the last quarter. Finally, Sendero Wealth Management LLC boosted its position in Henry Schein by 17.2% during the 1st quarter. Sendero Wealth Management LLC now owns 14,366 shares of the company's stock worth $984,000 after acquiring an additional 2,105 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Barrington Research lowered their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Finally, UBS Group decreased their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $79.30.

Insider Activity at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by company insiders.

Henry Schein Price Performance

Henry Schein stock traded down $0.89 during trading hours on Friday, hitting $70.19. 1,480,510 shares of the stock were exchanged, compared to its average volume of 1,685,276. The stock has a market capitalization of $8.54 billion, a P/E ratio of 28.88, a P/E/G ratio of 2.13 and a beta of 0.86. The business's 50-day moving average is $68.15 and its two-hundred day moving average is $71.52. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the prior year, the company earned $1.10 EPS. Henry Schein's revenue for the quarter was down .1% on a year-over-year basis. Equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.